PFKFB3 kinase inhibitors (Nimbus Discovery)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePFKFB3 kinase inhibitors (Nimbus Discovery)
Drug Alias Name6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 kinase inhibitors (Nimbus Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 inhibitors
Targets6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNimbus Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNimbus Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A